Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Grand View Research, Inc. | PRODUCT CODE: 1133330

Cover Image

PUBLISHER: Grand View Research, Inc. | PRODUCT CODE: 1133330

Monkeypox Testing Market Size, Share & Trends Analysis Report By Technology (PCR, FA), By End-use (Hospitals & Clinics, Diagnostic Laboratories), By Region (Europe, North America), And Segment Forecasts, 2022 - 2030

PUBLISHED:
PAGES: 80 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

Monkeypox Testing Market Growth & Trends:

The global monkeypox testing market size is expected to reach USD 2.63 million by 2030, according to a new report by Grand View Research, Inc. expanding at a CAGR of 4.35% from 2022 to 2030. The industry growth is attributed to the increasing incidence of monkeypox cases along with the population growth concerns for the occurrence of another pandemic worldwide. The CDC reports that as of 22 August 2022, there were 94,385 laboratory tests conducted with a cumulative positivity rate of 29.7%; there were a total of 56,609 global cases, with the majority of cases from the U.S. totaling 21,504. The rising cases stimulate the need to develop precise diagnostic as well as treatment options and testing capabilities to curb the spread of the virus.

There is an increasing demand to understand the physiology of the virus so that a proper procedural step for testing, diagnosis, and treatment can be postulated. A wide range of testing kits are being developed to diagnose the disease; however, a proper way to understand the spread is still under examination. Moreover, government initiatives to increase testing are propelling the growth of the market. For instance, in September 2022, the U.S. FDA announced steps and significant actions to increase the diagnostics capacity and accessibility as part of its continued commitment to address ongoing outbreaks. The launch of novel diagnostic tests that use PCR technology is being introduced that utilize the enhanced laboratory capacity during the pandemic, facilitating the easier adoption of tests.

Key players operating in the global market are focusing on product launches and increasing their testing capacities to meet the rising demand for early diagnosis and to strengthen their industry position. For instance, in June 2022, The Clinical Virology Laboratory at Stanford Medicine introduced a diagnostic test for the monkeypox virus, which has been found in 42 countries and several U.S. states, including California. The test will aid in public health initiatives aimed at halting the virus's spread and expediting accurate diagnosis. The partnerships between key players focusing on research and developing testing kits are highly common, which allows these companies to receive funding and use the expertise of bigger diagnostic companies.

Monkeypox Testing Market Report Highlights:

  • The PCR technology segment accounted for the largest share of the overall revenue due to the easy availability and rapid tests offered with this technology
  • The hospitals and clinics end-use segment is expected to grow at the fastest growth rate during the forecast period
  • This is mainly due to the easy access to novel disease diagnostics and increasing patient awareness about the same
  • North America dominated the global industry in 2022 and is also anticipated to be the fastest-growing regional market during the forecast period
  • The fast-paced growth can be credited to the presence of highly established research facilities in the region for the development of novel products
Product Code: GVR-4-68039-982-0

Table of Contents

Chapter 1 Monkeypox Testing Market: Methodology And Scope

  • 1.1 Research Methodology
  • 1.2 Research Assumptions
    • 1.2.1 Estimates and forecast timeline
  • 1.3 Information Procurement
    • 1.3.1 Purchased database
    • 1.3.2 GVR's internal database
    • 1.3.3 Secondary sources
    • 1.3.4 Primary research
    • 1.3.5 Details of primary research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data analysis models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity flow analysis
      • 1.6.1.1 Approach 1: Commodity flow approach
    • 1.6.2 Volume price analysis (model 2)
      • 1.6.2.1 Approach 2: Volume price analysis
      • 1.6.2.2 Revenue modeling
  • 1.7 List of Secondary Sources
  • 1.8 List of Primary Sources

Chapter 2 Monkeypox Testing Market: Executive Summary

  • 2.1 Monkeypox Testing Market: Market Outlook
    • 2.1.1 Market summary
  • 2.2 Monkeypox Testing Market: Market Segmentation
  • 2.3 Monkeypox Testing Market: Competitive Insights

Chapter 3 Monkeypox Testing Market: Industry Outlook

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
  • 3.2 Penetration & Growth Prospect Mapping for monkeypox testing, 2022
  • 3.3 Market Dynamics
    • 3.3.1 Market driver analysis
      • 3.3.1.1 Increasing prevalence of monkeypox cases
      • 3.3.1.2 Increasing awareness among the population
      • 3.3.1.3 Advancements in diagnosis research
      • 3.3.1.4 Increased government funding and initiatives
    • 3.3.2 Market restraint analysis
      • 3.3.2.1 Difficulty in determining the cause of the spread
  • 3.4 Monkeypox Testing Market - Porter's Analysis
    • 3.4.1 Porter's analysis
      • 3.4.1.1 Competitive rivalry
      • 3.4.1.2 Threat of new entrants
      • 3.4.1.3 Threat of substitutes
      • 3.4.1.4 Bargaining power of suppliers
      • 3.4.1.5 Bargaining power of buyers
  • 3.5 Monkeypox Testing Market - SWOT Analysis
    • 3.5.1 Political and legal
      • 3.5.1.1 Strengths
      • 3.5.1.2 Weaknesses
      • 3.5.1.3 Opportunities
      • 3.5.1.4 Threats
    • 3.5.2 Economic
      • 3.5.2.1 Strengths
      • 3.5.2.2 Weakness
      • 3.5.2.3 Opportunity
      • 3.5.2.4 Threat
    • 3.5.3 Technological
      • 3.5.3.1 Strengths
      • 3.5.3.2 Weakness
      • 3.5.3.3 Opportunity
      • 3.5.3.4 Threat
  • 3.6 Monkeypox Testing Market - Regulatory Framework
  • 3.7 Monkeypox Testing Market - User Perspective Analysis

Chapter 4 Monkeypox Testing Market: Competitive Landscape

  • 4.1 Company/Competition Categorization (Key Innovators, Market leaders, Emerging Players)
  • 4.2 Strategy Framework
  • 4.3 Market Participation Categorization
  • 4.4 Recent Developments & Impact Analysis, by Key Market Participants
  • 4.5 Company Position Analysis
  • 4.6 List of Distributors
    • 4.6.1 Key Customers
    • 4.6.2 Public Companies
    • 4.6.3 Private Companies
  • 4.7 Major Deals and Strategic Alliances
    • 4.7.1 Joint Ventures
    • 4.7.2 Acquisitions
    • 4.7.3 Licensing and Partnerships
    • 4.7.4 Technological Collaborations

Chapter 5 Monkeypox Testing Market: Technology Business Analysis

  • 5.1 Definition and Scope
  • 5.2 Technology Market Share Analysis, 2022 & 2030
  • 5.3 Segment Dashboard
  • 5.4 Global Monkeypox Testing Market, By Technology, 2018 to 2030
  • 5.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 5.5.1 Polymerase Chain Reaction (PCR)
      • 5.5.1.1 Polymerase chain reaction (PCR) market 2018 - 2030 (USD Million)
    • 5.5.2 Lateral Flow Assay (LFA)
      • 5.5.2.1 Lateral flow assay market, 2018 - 2030 (USD Million)
    • 5.5.3 Others
      • 5.5.3.1 Others market, 2018 - 2030 (USD Million)

Chapter 6 Monkeypox Testing Market: End-use Business Analysis

  • 6.1 Definition and Scope
  • 6.2 End-Use Market Share Analysis, 2022 & 2030
  • 6.3 Segment Dashboard
  • 6.4 Global Monkeypox Testing Market Market, By End-Use, 2018 to 2030
  • 6.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 6.5.1 Hospitals & Clinics
      • 6.5.1.1 Hospitals & clinics market 2018 - 2030 (USD Million)
    • 6.5.2 Diagnostic Laboratories
      • 6.5.2.1 Diagnostic Laboratories market, 2018 - 2030 (USD Million)
    • 6.5.3 Others
      • 6.5.3.1 Others market, 2018 - 2030 (USD Million)

Chapter 7 Monkeypox Testing Market: Regional Business Analysis

  • 7.1 Definition & Scope
  • 7.2 Regional Market Share Analysis, 2022 & 2030
  • 7.3 Regional Market Dashboard
  • 7.4 Regional Market Snapshot
  • 7.5 SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
    • 7.5.1 North America
    • 7.5.2 Europe
    • 7.5.3 Asia Pacific
    • 7.5.4 Latin America
    • 7.5.5 MEA
  • 7.6 Market Size, & Forecasts, Trend Analysis, 2022 to 2030
  • 7.7 North America
    • 7.7.1 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.7.2 U.S.
      • 7.7.2.1 U.S. monkeypox testing market, 2018 - 2030 (USD Million)
    • 7.7.3 Canada
      • 7.7.3.1 Canada monkeypox testing market, 2018 - 2030 (USD Million)
  • 7.8 Europe
    • 7.8.1 Europe monkeypox testing market, 2018 - 2030 (USD Million)
    • 7.8.2 U.K.
      • 7.8.2.1 U.K. monkeypox testing market, 2018 - 2030 (USD Million)
    • 7.8.3 Germany
      • 7.8.3.1 Germany monkeypox testing market, 2018 - 2030 (USD Million)
    • 7.8.4 Spain
      • 7.8.4.1 Spain monkeypox testing market, 2018 - 2030 (USD Million)
    • 7.8.5 France
      • 7.8.5.1 France monkeypox testing market, 2018 - 2030 (USD Million)
    • 7.8.6 Italy
      • 7.8.7.1 Italy monkeypox testing market, 2018 - 2030 (USD Million)
  • 7.9 Asia Pacific
    • 7.9.1 Asia-Pacific Monkeypox Testing Market, 2018 - 2030 (USD Million)
    • 7.9.2 Japan
      • 7.9.2.1 Japan monkeypox testing market, 2018 - 2030 (USD Million)
    • 7.9.3 China
      • 7.9.3.1 China monkeypox testing market, 2018 - 2030 (USD Million)
    • 7.9.4 India
      • 7.9.4.1 India monkeypox testing market, 2018 - 2030 (USD Million)
    • 7.9.5 South Korea
      • 7.9.5.1 South Korea monkeypox testing market, 2018 - 2030 (USD Million)
    • 7.9.6 Australia
      • 7.9.6.1 Australia monkeypox testing market, 2018 - 2030 (USD Million)
  • 7.10 Latin America
    • 7.10.1 Latin America Monkeypox Testing Market, 2018 - 2030 (USD Million)
    • 7.10.2 Brazil
      • 7.10.2.1 Brazil monkeypox testing market, 2018 - 2030 (USD Million)
    • 7.10.3 Mexico
      • 7.10.3.1 Mexico monkeypox testing market, 2018 - 2030 (USD Million)
    • 7.10.4 Argentina
      • 7.10.4.1 Argentina monkeypox testing market, 2018 - 2030 (USD Million)
  • 7.11 MEA
    • 7.11.1 MEA Monkeypox Testing Market, 2018 - 2030 (USD Million)
    • 7.11.2 South Africa
      • 7.11.2.1 South Africa monkeypox testing market, 2018 - 2030 (USD Million)
    • 7.11.3 Saudi Arabia
      • 7.11.3.1 Saudi Arabia monkeypox testing market, 2018 - 2030 (USD Million)
    • 7.11.4 UAE
      • 7.11.4.1 UAE monkeypox testing market, 2018 - 2030 (USD Million)

Chapter 8 Monkeypox Testing Market: Company Profiling

  • 8.1 Company Profiles
    • 8.1.1 Sonic Healthcare Limited
      • 8.1.1.1 Company Overview
      • 8.1.1.2 Financial Performance
      • 8.1.1.3 Product Benchmarking
      • 8.1.1.4 Strategic Initiatives
    • 8.1.2. Aegis Sciences Corporation
      • 8.1.2.1 Company Overview
      • 8.1.2.2 Financial Performance
      • 8.1.2.3 Product Benchmarking
      • 8.1.2.4 Strategic Initiatives
    • 8.1.3. Quest Diagnostics Incorporated
      • 8.1.3.1 Company Overview
      • 8.1.3.2 Financial Performance
      • 8.1.3.3 Product Benchmarking
      • 8.1.3.4 Strategic Initiatives
    • 8.1.4. Laboratory Corporation of America Holdings
      • 8.1.4.1 Company Overview
      • 8.1.4.2 Financial Performance
      • 8.1.4.3 Product Benchmarking
      • 8.1.4.4 Strategic Initiatives
    • 8.1.5. QIAGEN
      • 8.1.5.1 Company Overview
      • 8.1.5.2 Financial Performance
      • 8.1.5.3 Product Benchmarking
      • 8.1.5.4 Strategic Initiatives
    • 8.1.6. Mayo Clinic Laboratories
      • 8.1.6.1 Company Overview
      • 8.1.6.2 Financial Performance
      • 8.1.6.3 Product Benchmarking
      • 8.1.6.4 Strategic Initiatives
    • 8.1.7. Chembio Diagnostics, Inc.
      • 8.1.7.1 Company Overview
      • 8.1.7.2 Financial Performance
      • 8.1.7.3 Product Benchmarking
      • 8.1.7.4 Strategic Initiatives
    • 8.1.8. Sonora Quest Laboratories
      • 8.1.8.1 Company Overview
      • 8.1.8.2 Financial Performance
      • 8.1.8.3 Product Benchmarking
      • 8.1.8.4 Strategic Initiatives
    • 8.1.9. Thermo Fisher Scientific Inc.
      • 8.1.9.1 Company Overview
      • 8.1.9.2 Financial Performance
      • 8.1.9.3 Product Benchmarking
      • 8.1.9.4 Strategic Initiatives
    • 8.1.10. BD
      • 8.1.10.1 Company Overview
      • 8.1.10.2 Financial Performance
      • 8.1.10.3 Product Benchmarking
      • 8.1.10.4 Strategic Initiatives
Product Code: GVR-4-68039-982-0

List of Tables

  • TABLE 1 List of Secondary Sources
  • TABLE 2 List of Abbreviations
  • TABLE 3 Regulatory Framework
  • TABLE 4 Global Monkeypox Testing Market, By Region, 2018 - 2030 (USD Million)
  • TABLE 5 Global Monkeypox Testing Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 6 Global Monkeypox Testing Market, By End-use
  • TABLE 7 North America Monkeypox Testing Market, By Country, 2018 - 2030 (USD Million)
  • TABLE 8 North America Monkeypox Testing Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 9 North America Monkeypox Testing Market, By End-use, 2018 - 2030 (USD Million)
  • TABLE 10 U.S. Monkeypox Testing Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 11 U.S. Monkeypox Testing Market, By End-use, 2018 - 2030 (USD Million)
  • TABLE 12 Canada Monkeypox Testing Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 13 Canada Monkeypox Testing Market, By End-use, 2018 - 2030 (USD Million)
  • TABLE 14 Europe Monkeypox Testing Market, By Country, 2018 - 2030 (USD Million)
  • TABLE 15 Europe Monkeypox Testing Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 16 Europe Monkeypox Testing Market, By End-use, 2018 - 2030 (USD Million)
  • TABLE 17 U.K. Monkeypox Testing Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 18 U.K. Monkeypox Testing Market, By End-use, 2018 - 2030 (USD Million)
  • TABLE 19 Germany Monkeypox Testing Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 20 Germany Monkeypox Testing Market, By End-use, 2018 - 2030 (USD Million)
  • TABLE 21 France Monkeypox Testing Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 22 France Monkeypox Testing Market, By End-use, 2018 - 2030 (USD Million)
  • TABLE 23 Spain Monkeypox Testing Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 24 Spain Monkeypox Testing Market, By End-use, 2018 - 2030 (USD Million)
  • TABLE 25 Italy Monkeypox Testing Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 26 Italy Monkeypox Testing Market, By End-use, 2018 - 2030 (USD Million)
  • TABLE 27 Asia Pacific Monkeypox Testing Market, By Country, 2018 - 2030 (USD Million)
  • TABLE 28 Asia Pacific Monkeypox Testing Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 29 Asia Pacific Monkeypox Testing Market, By End-use, 2018 - 2030 (USD Million)
  • TABLE 30 China Monkeypox Testing Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 31 China Monkeypox Testing Market, By End-use, 2018 - 2030 (USD Million)
  • TABLE 32 Japan Monkeypox Testing Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 33 Japan Monkeypox Testing Market, By End-use, 2018 - 2030 (USD Million)
  • TABLE 34 India Monkeypox Testing Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 35 India Monkeypox Testing Market, By End-use, 2018 - 2030 (USD Million)
  • TABLE 36 South Korea Monkeypox Testing Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 37 South Korea Monkeypox Testing Market, By End-use, 2018 - 2030 (USD Million)
  • TABLE 38 Australia Monkeypox Testing Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 39 Australia Monkeypox Testing Market, By End-use, 2018 - 2030 (USD Million)
  • TABLE 40 Latin America Monkeypox Testing Market, By Country, 2018 - 2030 (USD Million)
  • TABLE 41 Latin America Monkeypox Testing Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 42 Latin America Monkeypox Testing Market, By End-use, 2018 - 2030 (USD Million)
  • TABLE 43 Brazil Monkeypox Testing Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 44 Brazil Monkeypox Testing Market, By End-use, 2018 - 2030 (USD Million)
  • TABLE 45 Mexico Monkeypox Testing Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 46 Mexico Monkeypox Testing Market, By End-use, 2018 - 2030 (USD Million)
  • TABLE 47 Argentina Monkeypox Testing Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 48 Argentina Monkeypox Testing Market, By End-use, 2018 - 2030 (USD Million)
  • TABLE 49 MEA Monkeypox Testing Market, By Country, 2018 - 2030 (USD Million)
  • TABLE 50 MEA Monkeypox Testing Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 51 MEA. Monkeypox Testing Market, By End-use, 2018 - 2030 (USD Million)
  • TABLE 52 South Africa Monkeypox Testing Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 53 South Africa Monkeypox Testing Market, By End-use, 2018 - 2030 (USD Million)
  • TABLE 54 UAE Monkeypox Testing Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 55 UAE Monkeypox Testing Market, By End-use, 2018 - 2030 (USD Million)
  • TABLE 56 Saudi Arabia Monkeypox Testing Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 57 Saudi Arabia Monkeypox Testing Market, By End-use, 2018 - 2030 (USD Million)

List of Figures

  • FIG. 1 Monkeypox testing market segmentation
  • FIG. 2 Market research process
  • FIG. 3 Information procurement
  • FIG. 4 Primary research pattern
  • FIG. 5 Market research approaches
  • FIG. 6 Value-chain-based sizing & forecasting
  • FIG. 7 QFD modeling for market share assessment
  • FIG. 8 Market formulation & validation
  • FIG. 9 Primary interviews, by sources
  • FIG. 10 Primary interviews, by region
  • FIG. 11 Monkeypox testing market summary
  • FIG. 12 Market driver relevance analysis (Current & future impact)
  • FIG. 13 Estimated number of cancer cases (5 year) worldwide
  • FIG. 14 New cases of cancer worldwide (2018)
  • FIG. 15 Monkeypox testing market restraint impact
  • FIG. 16 Penetration and growth prospect mapping
  • FIG. 17 User perspective analysis
  • FIG. 18 SWOT analysis, by factor (political & legal, economic and technological)
  • FIG. 19 Porter's five forces analysis
  • FIG. 20 High potency active pharmaceutical ingredients technology outlook: Key takeaways
  • FIG. 21 Monkeypox testing market: Technology movement analysis
  • FIG. 22 Polymerase chain reaction market, 2018 - 2030 (USD Million)
  • FIG. 23 Lateral flow assay (LFA) market, 2018 - 2030 (USD Million)
  • FIG. 24 Others market, 2018 - 2030 (USD Million)
  • FIG. 25 Monkeypox testing market end-use outlook: Key takeaways
  • FIG. 26 Monkeypox testing market: End-use movement analysis
  • FIG. 27 Hospital and clinics market, 2018 - 2030 (USD Million)
  • FIG. 28 Diagnostic laboratories market, 2018 - 2030 (USD Million)
  • FIG. 29 Others market, 2018 - 2030 (USD Million)
  • FIG. 30 Regional marketplace: Key takeaways
  • FIG. 31 Regional outlook, 2020 & 2028
  • FIG. 32 North America
  • FIG. 33 North America. market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 34 U.S.
  • FIG. 35 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 36 Canada
  • FIG. 37 Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 38 Europe
  • FIG. 39 Europe market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 40 U.K.
  • FIG. 41 U.K. market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 42 Germany
  • FIG. 43 Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 44 France
  • FIG. 45 France market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 46 Spain
  • FIG. 47 Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 48 Italy
  • FIG. 49 Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 50 Asia-Pacific
  • FIG. 51 Asia-Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 52 Japan
  • FIG. 53 Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 54 China
  • FIG. 55 China. market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 56 India
  • FIG. 57 India market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 58 Australia
  • FIG. 59 Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 60 South Korea
  • FIG. 61 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 62 Latin America
  • FIG. 63 Latin America. market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 64 Brazil
  • FIG. 65 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 66 Mexico
  • FIG. 67 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 68 Argentina
  • FIG. 69 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 70 Middle East & Africa
  • FIG. 71 MEA market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 72 South Africa
  • FIG. 73 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 74 Saudi Arabia
  • FIG. 75 Saudi Arabia market estimates and forecast, 2018 - 2030 USD Million
  • FIG. 76 UAE
  • FIG. 77 UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 78 Ansoff Matrix
  • FIG. 79 Strategy mapping
  • FIG. 80 Company/Competition Categorization
  • FIG. 81 Heat Map Analysis
  • FIG. 82 Regional Network Map
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!